Opioids Offer Only Minor Pain Relief in Osteoarthritis
Opioids have no impact on QoL or depression; smaller benefits seen for pain for strong versus weak opioids
ACR 2019
Ixekizumab vs Adalimumab in Psoriatic Arthritis: 52-Week Data Announced
Ixekizumab demonstrated superiority to adalimumab in achieving simultaneous joint and skin improvement in biologic-naive patients with active psoriatic arthritis, according to data from the phase 3b/4 SPIRIT Head-to-Head (H2H) study.
Tildrakizumab-asmn Effective in Psoriatic Arthritis Study
Tildrakizumab-asmn demonstrated significant improvements to swollen and tender joint counts and pain in patients with active psoriatic arthritis (PsA), according to phase 2b interim results.
Decrease in Giant Cell Arteritis Relapse Risk With Elevated Platelet Count
Researchers studied the risk factors for relapse, including prednisolone clearance and glucocorticoid-induced transcript 1 promoter polymorphism (rs37972), in patients with giant cell arteritis.
Glucocorticoid Use Associated With Increased Risk for Cardiovascular Disease in SLE
Researchers addressed the association between cardiovascular risk and glucocorticoids in patients with systemic lupus erythematosus.
Fracture Risk, BMD Improvement With Abaloparatide Plus Alendronate in Osteoporosis, OA
In this post hoc analysis, researchers evaluated the efficacy and safety of abaloparatide followed by alendronate vs placebo followed by alendronate in a subgroup of patients with osteoarthritis.
Sublingual Cyclobenzaprine Shows Clinically Meaningful Effects on Pain, Sleep Measures in Fibromyalgia
Researchers evaluated the safety and efficacy of a sublingual formulation of cyclobenzaprine in fibromyalgia.
Diagnoses of RA, SLE Linked to Increased Opioid Overdose Hospitalization Risk
Researchers compared the rate of opioid overdose-related hospitalizations among patients with systemic lupus erythematosus and rheumatoid arthritis vs the general population.
Guselkumab Demonstrates Efficacy in Biologic-Naive or TNFi-Treated Patients With Psoriatic Arthritis
Researchers evaluated the efficacy and safety of guselkumab in patients with active psoriatic arthritis who were biologic-naive or treated with prior tumor necrosis factor inhibitors.
Diclofenac 1% Gel Improves Knee Osteoarthritis Symptoms Regardless of BMI
Researchers determined whether body mass index had any clinical impact on the efficacy of diclofenac sodium gel 1% in patients with knee osteoarthritis.
